Improving Diagnosis Of Early Frontotemporal Dementia Syndromes
Funder
National Health and Medical Research Council
Funding Amount
$451,716.00
Summary
Frontotemporal dementia is difficult to identify and diagnose accurately, although it is almost as common as Alzheimer’s disease before the age of 65. Improving its detection and diagnostic accuracy is the focus of my fellowship for the next 4 years. As a neuropsychologist with over 15 years clinical experience in dementia, I will combine clinical, neuroimaging and neuropathological approaches to identify early presentations of frontotemporal dementia and other dementia syndromes.
Early Identification Of Degenerative Dementia Syndromes
Funder
National Health and Medical Research Council
Funding Amount
$380,558.00
Summary
With the continuing ageing of the population, an increasing number of adults will experience signs of dementia. Knowledge of the clinical presentation, disease mechanisms and evolution of frontotemporal dementia, a syndrome as common as Alzheimer’s disease in the < 65 year-old group, remains suboptimal. This research project will combine clinical investigations and brain imaging to improve diagnostic accuracy of this disease. This will lead to better treatment and management interventions.
To reduce Australia's future dementia burden, it is imperative to develop methods to identify those Australians at the very early stage of dementia. To achieve this goal, we are establishing multidisciplinary research projects to track disease progression from the very early stage. These projects use cutting-edge neuroscience technologies to examine how the mind and brain change in dementia. My goal is to discover novel methods for early detection, and develop early intervention strategies.
Regenerative Neuroscience Strategies For Healthy Brain Ageing And Dementia
Funder
National Health and Medical Research Council
Funding Amount
$463,652.00
Summary
Promotion of healthy brain ageing and prevention of dementia are amongst Australia's greatest medical challenges and of utmost concern to the public. This Fellowship will support a multidisciplinary approach to these challenges based around regenerative neuroscience. Valenzuela's group is a world leader in the science and practice of brain plasticity, and will lead twelve interlinked studies aimed at developing better ways to prevent dementia.
Regenerative Neuroscience Strategies For Brain Ageing And Dementia
Funder
National Health and Medical Research Council
Funding Amount
$426,079.00
Summary
Dementia is the pre-eminent medical challenge of our times as it affects 34 million individuals and will quadruple by 2050. This research therefore aims to develop new preventative and therapeutic strategies for dementia. Seven different studies are proposed, ranging from new stem-cell treatments for testing in rodents, to human clinical trials looking at the preventative effects of physical and mental exercise. These are linked by a central idea of boosting the brain’s neuroplasticity.
Is Stroke Neurodegenerative? A Longitudinal Study Of Changes In Brain Volume And Cognition Following Stroke
Funder
National Health and Medical Research Council
Funding Amount
$290,946.00
Summary
There is no direct evidence linking Alzheimer’s Disease (AD) and stroke. It is unknown whether stroke can trigger progressive dementia in the same way as AD. In a group of stroke patients, I will measure MRI brain volume and cognition in the 5 years after stroke. These findings will be critical for identification of those patients most at risk of dementia after stroke. This may allow future early intervention for these patients, via promising AD disease-modifying therapies.
The aim is to make life safer for at-risk older people and to give them the capacity to participate in daily life activity. Transition from hospital to home and accidental falls are two events in which a lack of capacity to make adaptive changes or resume previous life activities can alter life course outcomes. I will engage in effectiveness trials of interventions and research to ensure the implementation of new knowledge into clinical and public health practice.
Neurodegenerative Disease Pathology, Mechanisms, Models And Treatments
Funder
National Health and Medical Research Council
Funding Amount
$431,000.00
Summary
Frontotemporal dementia (FTD) and motor neuron disease (MND) are fatal and incurable neurodegenerative diseases. Although dissimilar in symptoms, most cases of both FTD and MND are characterised at autopsy by abnormal accumulations of the TDP-43 protein in neurons. In this fellowship, I will characterise the biochemical changes caused by TDP-43 malfunction that occur in both FTD and MND and test potential new therapeutics in mice, to identify new ways to treat these devastating diseases.